PROVECTUS BIOPHARMACEUTICALS, INC. Accounts Payable
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Accounts Payable of $931.97 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $931.97K.
- 2026-03-31: Accounts Payable, Current $815.32K.
- 2025-12-31: Accounts Payable, Current $716.22K.
- 2025-09-30: Accounts Payable, Current $1.18M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $931.97K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $815.32K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $716.22K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.18M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.31M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $743.97K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.11M 10-K · filed 2026-03-26 |
| 2024-09-30 | $1.38M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.32M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.37M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.68M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.79M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.99M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.91M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.09M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.94M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.89M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.60M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.29M 10-K · filed 2023-03-30 |
| 2020-12-31 | $956.86K 10-K · filed 2022-03-29 |
| 2013-12-31 | $348.87K 10-K · filed 2014-03-13 |
| 2012-12-31 | $243.44K 10-K · filed 2014-03-13 |